This slide deck contains content created, reviewed,
Connected for Life. and approved by the American Diabetes
Association® (ADA). You are free to use the slides in
presentations without further permission as long as
the slide content is not altered in any way and
appropriate attribution is made to the ADA (the ADA's
name and logo on the slides constitutes appropriate
attribution). Permission is required from the ADA for
any commercial use or for reproduction in any print
materials (contact permissions@[Link]).
STANDARDS OF CARE IN DIABETES 2024
Abridged for Primary Care Professionals
Published annually in Clinical Diabetes
Contains evidence-based recommendations most pertinent to primary care
Recommendations are substantively the same as in the complete Standards of Care
Access:
Abridged Standards of Care — [Link]/clinical
Complete Standards of Care and all supporting references — [Link]/standards
2
Section 1
Improving Care and
Promoting Health in Populations
STANDARDS OF CARE: SECTION 1
Improving Care and Promoting Health in
Populations
A multifaceted approach encompassing patient-level, system-level, and policy-level interventions is crucial for enhancing population health
in the context of diabetes. This approach may include the following key elements.
4
Section 2
Diagnosis and Classification of Diabetes
STANDARDS OF CARE: SECTION 2
Diagnostic Tests for Diabetes
6
STANDARDS OF CARE: SECTION 2
Classification
Classification of diabetes type is not always straightforward at presentation, and misdiagnosis is common.
7
STANDARDS OF CARE: SECTION 2
Screening Criteria for Prediabetes and Type 2
Diabetes
Informal assessment of risk Validated risk calculator
factors
8
STANDARDS OF CARE: SECTION 2
Informal Risk Factor Assessment for Prediabetes
and Type 2 Diabetes
9
STANDARDS OF CARE: SECTION 2
Additional Screening Guidelines
10
Section 3
Prevention or Delay of Diabetes and
Associated Comorbidities
STANDARDS OF CARE: SECTION 3
Diet and Physical Activity Recommendations for
Adults at Risk for Type 2 Diabetes
12
STANDARDS OF CARE: SECTION 3
Person-Centered Care Goals for
Individuals at Risk of Type 2 Diabetes
13
STANDARDS OF CARE: SECTION 3
14
STANDARDS OF CARE: SECTION 3
15
STANDARDS OF CARE: SECTION 3
Staging of Type 1 Diabetes
16
Section 4
Comprehensive Medical Evaluation
and Assessment of Comorbidities
STANDARDS OF CARE: SECTION 4
Assessment of Comorbidities
18
STANDARDS OF CARE: SECTION 4
19
STANDARDS OF CARE: SECTION 4
20
STANDARDS OF CARE: SECTION 4
21
STANDARDS OF CARE: SECTION 4
Proposed Algorithm for Risk Stratification in Individuals with NAFLD or NASH.
22
STANDARDS OF CARE: SECTION 4
23
STANDARDS OF CARE: SECTION 4
Components of the Comprehensive Diabetes Medical Evaluation at Initial, Follow-Up, and Annual Visits
24
STANDARDS OF CARE: SECTION 4
Components of the Comprehensive Diabetes Medical Evaluation at Initial, Follow-Up, and Annual Visits
25
STANDARDS OF CARE: SECTION 4
Components of the Comprehensive Diabetes Medical Evaluation at Initial, Follow-Up, and Annual Visits
26
STANDARDS OF CARE: SECTION 4
Components of the Comprehensive Diabetes Medical Evaluation at Initial, Follow-Up, and Annual Visits
27
Section 5
Facilitating Positive Health Behaviors and
Well-Being to Improve Health Outcomes
STANDARDS OF CARE: SECTION 5
Building positive health behaviors and maintaining psychological well-being are foundational for achieving diabetes
management goals and maximizing quality of life.
29
STANDARDS OF CARE: SECTION 5
30
STANDARDS OF CARE: SECTION 5
Psychosocial Care for All People With Diabetes:
Considerations and Recommendations
31
STANDARDS OF CARE: SECTION 5
Psychosocial Care for All People With Diabetes:
Considerations and Recommendations
32
STANDARDS OF CARE: SECTION 5
33
STANDARDS OF CARE: SECTION 5
MNT
There is a no one-size-fits-all eating pattern. Successful MNT programs are:
34
STANDARDS OF CARE: SECTION 5
35
STANDARDS OF CARE: SECTION 5
36
STANDARDS OF CARE: SECTION 5
37
STANDARDS OF CARE: SECTION 5
38
Section 6
Glycemic Goals and Hypoglycemia
STANDARDS OF CARE: SECTION 6
40
STANDARDS OF CARE: SECTION 6
41
STANDARDS OF CARE: SECTION 6
Glucose Assessment via CGM:
The Ambulatory Glucose Profile (AGP) Report
42
STANDARDS OF CARE: SECTION 6
Glucose Assessment via CGM:
The Ambulatory Glucose Profile (AGP) Report
43
STANDARDS OF CARE: SECTION 6
44
STANDARDS OF CARE: SECTION 6
45
STANDARDS OF CARE: SECTION 6
46
STANDARDS OF CARE: SECTION 6
Hypoglycemia Assessment, Prevention, and Treatment
47
STANDARDS OF CARE: SECTION 6
Hypoglycemia Assessment, Prevention, and Treatment
48
Section 7
Diabetes Technology
STANDARDS OF CARE: SECTION 7
50
STANDARDS OF CARE: SECTION 7
51
STANDARDS OF CARE: SECTION 7
52
STANDARDS OF CARE: SECTION 7
53
STANDARDS OF CARE: SECTION 7
54
STANDARDS OF CARE: SECTION 7
55
Section 8
Obesity and Weight Management for the
Prevention and Treatment of Type 2 Diabetes
STANDARDS OF CARE: SECTION 8
57
STANDARDS OF CARE: SECTION 8
58
STANDARDS OF CARE: SECTION 8
59
STANDARDS OF CARE: SECTION 8
60
STANDARDS OF CARE: SECTION 8
61
STANDARDS OF CARE: SECTION 8
62
Section 9
Pharmacologic Approaches to
Glycemic Treatment
STANDARDS OF CARE: SECTION 9
64
STANDARDS OF CARE: SECTION 9
65
STANDARDS OF CARE: SECTION 9 Use of Glucose-Lowering Medications in the
Management of Type 2 Diabetes
66
STANDARDS OF CARE: SECTION 9
67
Section 10
Cardiovascular Disease and Risk Management
STANDARDS OF CARE: SECTION 10
69
STANDARDS OF CARE: SECTION 10
70
STANDARDS OF CARE: SECTION 10
71
STANDARDS OF CARE: SECTION 10
72
STANDARDS OF CARE: SECTION 10
73
STANDARDS OF CARE: SECTION 10
74
Section 11
Chronic Kidney Disease and Risk Management
STANDARDS OF CARE: SECTION 11
76
STANDARDS OF CARE: SECTION 11
77
STANDARDS OF CARE: SECTION 11
78
STANDARDS OF CARE: SECTION 11
79
STANDARDS OF CARE: SECTION 11
80
Section 12
Retinopathy, Neuropathy, and Foot Care
STANDARDS OF CARE: SECTION 12
82
STANDARDS OF CARE: SECTION 12
83
STANDARDS OF CARE: SECTION 12
84
STANDARDS OF CARE: SECTION 12
85
STANDARDS OF CARE: SECTION 12
Neuropathy
Treatment
Various drugs may reduce pain from DPN, and both drug and non-drug strategies may
ease symptoms of DPN and autonomic neuropathy.
The safest and most evidence-based pharmacologic options for DPN include
gabapentinoids, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants,
and sodium channel blockers.
Refer to a neurologist or pain specialist when pain control is not achieved within the
scope of practice of the treating clinician.
86
STANDARDS OF CARE: SECTION 12
87
STANDARDS OF CARE: SECTION 12
88
Section 13
Older Adults
STANDARDS OF CARE: SECTION 13
90
STANDARDS OF CARE: SECTION 13
Simplification of Complex Insulin Therapy
91
Section 14
Children and Adolescents
STANDARDS OF CARE: SECTION 14
93
STANDARDS OF CARE: SECTION 14
94
STANDARDS OF CARE: SECTION 14
Addressing Probable New
Cases of Type 2 Diabetes in
Youth
95
Section 15
Management of Diabetes in Pregnancy
STANDARDS OF CARE: SECTION 15
97
STANDARDS OF CARE: SECTION 15
98
STANDARDS OF CARE: SECTION 15
99
STANDARDS OF CARE: SECTION 15
100
STANDARDS OF CARE: SECTION 15
101
Section 16
Diabetes Care in the Hospital
STANDARDS OF CARE: SECTION 16
103
STANDARDS OF CARE: SECTION 16
104
STANDARDS OF CARE: SECTION 16
105
STANDARDS OF CARE: SECTION 16
106
